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CASE REPORT
Spinal intradural metastasis 
from scapular Ewing sarcoma
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Abstract 
Background: Ewing sarcoma is a primary bone neoplasm, which is a high grade aggressive small round blue cell 
tumour, and is currently recognized as a part of the Ewing family of tumours. It is the most lethal bone tumor, and 
is a rare malignant bone tumor accounting for 10% of all primary bone tumors, and 6% of malignant bone tumors. 
It has an average annual incidence of 3 per 1 million, found almost exclusively in Caucasians. It commonly occurs in 
long bones and pelvis but rarely involves the scapula. 85% of cases have metastasis within 2 years of diagnosis, rarely 
involving the meninges.
Case presentation: We report a case of a 25 year old Sinhalese Sri Lankan female, presenting with a 1 day history of 
bilateral lower limb weakness and urinary incontinence. She had a sensory level with flaccid paralysis of lower limbs 
and a painless bony lump in the left dorsal scapula. Investigations showed scapular primary Ewing sarcoma giving 
rise to spinal intradural metastasis. For the best of our knowledge this is the first reported case of a scapular Ewing 
sarcoma with spinal intradural metastasis presenting with lower limb paralysis.
Conclusion: Intradural spinal metastasis of Ewing sarcoma presenting with lower limb weakness, without a history of 
pain, though rarely, can be the first presentation, and can rapidly progress to brainstem involvement and death.
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Background
Ewing sarcoma (ES) is a primary bone neoplasm which 
is a high grade aggressive small round blue cell tumour, 
and is currently recognized as a part of the Ewing fam-
ily of tumours. It was first described by famed pathologist 
James Ewing in 1921 [1, 2]. It commonly demonstrates 
reproducible staining of CD99 and translocations of the 
EWS gene. This neoplasm is usually associated with near 
certain metastasis at the time of diagnosis with a high 
rate of mortality. Occurrence of ES is frequently seen in 
the second decade of life in the diaphysis of long bones 
and pelvis; and has an average annual incidence of about 
3 per 1 million. It has a slight predominance in males 
which accounts for 61% of the cases diagnosed, and is 
found almost exclusively in Caucasians who represented 
92% of the cases [2].
Case presentation
A 25  year old Sinhalese Sri Lankan female presented 
with a 1 day history of bilateral lower limb weakness, and 
numbness with urinary incontinence. She had no back 
pain and no history of constitutional symptoms such as 
fever, loss of appetite, or recent subjective weight loss.
On examination she had atonic lower limbs, with 
absent muscle power, and absent bilateral lower limb 
reflexes below knee level, with sensory impairment up 
to T6 level. She had no spinal deformities or tender-
ness, and no papilloedema. Upper limb examination was 
unremarkable except for a hard non tender bony mass 
on the left scapular region. She had a blood pressure of 
140/80 mmHg, pulse rate of 78 beats per minute and had 
no respiratory compromise.
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She was investigated with a suspicion of metastatic dis-
ease and X-ray of the left shoulder showed a soft tissue 
and bony mass on the dorsal aspect of the left scapula 
with multiple lytic lesions suggestive of a primary bone 
neoplasm (Figure  1), but chest radiograph, ultrasound 
scan of the neck, and Computed tomography (CT) of 
abdomen were normal. Magnetic resonance imaging 
(MRI) of the spine showed an intradural extramedul-
lary mass with an extra spinal component at C7-T2 level 
causing severe cord compression (Figure 2), hence intra-
venous dexamethasone regimen was started.
Ultrasound guided core needle biopsy from the left 
scapular mass showed malignant small round blue cell 
tumour suggestive of Ewing sarcoma. Blood investiga-
tions showed Heamoglobin of 9.2  g/dl, white blood cell 
count of 12  ×  103/μl, Erythrocyte sedimentation rate 
(ESR)of 150  mm/h, C-reactive protein level of 96  mg/l, 
normal liver enzyme levels and liver functions tests, and 
serum alkaline phosphate level of 173 μ/l. Her blood pic-
ture showed increased rouleaux formation with anaemia 
of chronic disease.
She had no improvement of symptoms following treat-
ment with dexamethasone. Before implementing on 
oncological management, 3  days after onset of symp-
toms, she developed sudden onset progressive ascending 
neurological impairment with upper limb and bulbar 
involvement, and unfortunately resulted with respiratory 
failure and death.
Discussion
ES, which is the most lethal bone tumor, is a rare malig-
nant bone tumor accounting for 10% of all primary bone 
tumors, and 6% of malignant bone tumors [3]. The com-
monest symptom of ES is a dull to severe pain which 
becomes persistent from about 1  month prior to diag-
nosis, and is seen in approximately 70% cases, unlike in 
this patient who had a painless mass [3]. Other features 
are fever, anemia, leukocytosis and increased ESR. ES is 
thought to be neuroectodermal in origin. More than 80% 
of ES occur during the first two decades of life, wherein 
Krieun has described the distribution of ES varying with 
age mirroring the distribution of marrow [4].
Figure 1 Radiograph of the left scapula. Radiograph of the left 
scapula showing a bony mass with multiple lytic lesions in the lateral 
and dorsal aspects.
Figure 2 MRI image of cervical and thoracic spine. There is an intra-
dural extra-medullary mass with an extraspinal component at C7-D2 
level causing cord compression and there is a paraspinal component 
at this level which shows some degree of enhancement. Intervening 
intervertebral discs are normal.
Page 3 of 4Ralapanawa et al. BMC Res Notes  (2015) 8:298 
ES more commonly occurs in tubular bone than in 
flat bone, and the commonest affected site is the pelvis 
(25%), followed in order of frequency by ribs, femurs, 
spine, tibias, fibulas, scapulas and other bones [4]. The 
primary site of tumor in this case was the scapula. How-
ever, malignant tumor of the scapula is rare, which may 
comprise of chondro-sarcoma, synovial sarcoma, ES, and 
metastasis [5]. This case presented with spinal intradural 
metastasis, whereas primary malignant sarcoma of the 
spine is rare accounting for 3.5–14.9% of primary bone 
sarcomas [6]. Metastasis occurs in up to 85% of patients 
within 2  years of diagnosis. Metastasis occurs to lungs 
(85%), bones (69%), pleura (46%), lymph nodes (46%), 
dura and/or meninges (27%) and central nervous system 
(12%) respectively [7].
Central nervous system involvement which is seen in 
10–35% of patients occurs by either spinal cord com-
pression or meningeal dissemination [8]. Most previ-
ous reports of central nervous system metastasis of ES 
showed involvement of the bony calvarium or brain par-
anchyma. Most such lesions were found to be located in 
an intracranial or extradural site, making epidural and 
intradural metastasis even rarer [9]. The commonest 
malignancies involving the spinal epidural space are met-
astatic lymphomas, nerve sheath tumors, meningiomas, 
hemangiomas and metastasis from systemic malignan-
cies. Primary extra-skeletal ES occurring in a paraver-
tebral location with a predilection to infiltrate through 
neural exit foramina have been rarely reported [10].
Microscopic characteristics typical of ES include, Peri-
odic acid-Schiff positive, diastase-digestible cytoplasmic 
material, clear cytoplasm with indistinct cellular borders, 
and the uniformity of small oval blue nuclei [11]. A his-
tology of small round cell bone tumor can be further con-
firmed as ES by immunohistochemical and cytogenetic 
analysis, which shows consistent chromosomal anomaly, 
the reciprocal translocation t(11; 22)(q24; q12) [12]. ES 
is classically described radiologically as a central, diaphy-
seal, lytic or rarely sclerotic tumor, with “onion skin” type 
periosteal reaction affecting a long bone associated with 
soft tissue mass [13]. MRI, which is superior to CT, is fre-
quently associated with a prominent soft tissue mass that 
contains areas of necrosis or hemorrhage [3].
The successful treatment of patients with ES requires 
systemic chemotherapy in conjunction with either sur-
gery or radiation therapy or both modalities for local 
tumor control. Prognosis depends on the size and loca-
tion of the tumor, presence or absence of tumor metas-
tasis, tumor response to therapy, age, and disease relapse, 
out of which the presence of distant metastasis having 
the worst prognosis as seen in this patient. The current 
long term survival of ES is found to be 60–70%. However, 
patients with metastasis only have a long term survival 
of 20%, despite aggressive treatment. Histological grades 
have no prognostic significance, but the presence of fever, 
anaemia, leukocytosis, elevated ESR, and lactate dehy-
drogenase have been reported to indicate more extensive 
disease and a worse prognosis [13].
Conclusion
Intradural spinal metastasis of ES presenting with lower 
limb weakness, without a history of pain, though rarely, 
can be the first presentation, and can rapidly progress to 
brainstem involvement and death.
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